Westpac Banking Corp’s Aimmune Therapeutics AIMT Stock Holding History

Westpac Banking Corp’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-73,860	Closed	-$2.54M	–	878
2020 Q3	$2.54M	Buy	+73,860	New	+$1.57M	0.03%	481

Westpac Banking Corp's AIMT Position: Q4 2020 in Review

Westpac Banking Corp sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 73,860 shares — an estimated $2.54M sold.

Westpac Banking Corp first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $2.54M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

Westpac Banking Corp reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
Westpac Banking Corp sold 73,860 Aimmune Therapeutics shares in Q4 2020, an estimated $2.54M.
Westpac Banking Corp first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
Westpac Banking Corp's Aimmune Therapeutics position peaked at $2.54M in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Westpac Banking Corp's 13F filing for Q4 2020, filed 11 Feb 2021.